IL17A and inflammatory bowel disease: This altered immune response promotes an increase in inflammatory mediators responsible for generating and maintaining inflammation in IBD, including pro-inflammatory cytokines such as interleukin (IL)-1β, IL-6, IL-17, tumor necrosis factor (TNF) α, prostaglandins, and nitric oxide (NO).